MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025.
The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.
Register for the Conference here.
Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.
For updates, follow us on Twitter
Day 1 - Today
March 26, 2025
11:00
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.
11:20
Introduction
11:25 - 11:55
Photronics (NASDAQ: PLAB)
Keynote speaker: Ted Moreau, Vice President IR
12:00 – 12:30
AtlasClear Holdings, Inc. (NASDAQ: ATCH)
Keynote speakers: Craig Ridenhour, President & John Schaible, Chairman and CEO
12:35 – 1:05
Bioxytran, Inc. (OTCQB: BIXT)
Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development
2:05 – 2:15
Highland Copper Company Inc. (OTCQB: HDRSF) (TSXV: HI)
Keynote speaker: Barry O’Shea, CEO
2:20 – 2:50
Vista Gold Corp. (NYSE American: VGZ) (TSX: VGZ)
Keynote speaker: Frederick Earnest – CEO
2:55 – 3:05
RUA Gold, Inc. (OTCQB: NZAUF) (TSXV: RUA)
Keynote speaker: Robert Eckford, CEO
Postponed
HydroGraph Clean Power Inc. (OTCQB: HGRAF) (CSE: HG)
Keynote speaker: Kjirstin Breure, President and CEO
3:25 - 3:35
Aethlon Medical, Inc. (NASDAQ: AEMD)
Keynote speakers: Jim Frakes, Acting CEO and CFO & Steven LaRosa, Chief Medical Officer
Postponed
GeoVax Labs, Inc. (NASDAQ: GOVX)
Keynote speakers: David Dodd, Chairman, President / CEO
Day 2 - Tomorrow
March 27, 2025
9:15
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.
9:35
Introduction
9:40 – 10:10
ASP Isotopes Inc. (NASDAQ: ASPI)
Keynote speaker: Paul Elliot Mann, CEO
10:15 – 10:45
Peloton Minerals Corp. (OTCQB: PMCCF) (CSE: PMC)
Keynote speaker: Edward L. Ellwood, President, CEO & Director
11:25 – 11:55
Ideal Power, Inc. (NASDAQ: IPWR)
Keynote speakers: Dan Brdar: President and CEO, & Tim Burns: CFO
12:35 – 1:05
NCS Multistage Holdings, Inc. (NASDAQ: NCSM)
Keynote speaker: Ryan Hummer, CEO & Director
1:45 - 2:15
Citizens, Inc. (NYSE: CIA)
Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO
2:20 – 2:50
Vivani Medical, Inc. (NASDAQ: VANI)
Keynote speaker: Adam Mendelsohn PHD, CEO
2:55 – 3:05
Energy Finders, Inc. (OTC Pink: EGYF)
Keynote Speaker: Keith Pivonski, VP
3:10 - 3:20
Brenmiller Energy, Ltd. (NASDAQ: BNRG)
Keynote speaker: Nir Brenmiller, COO
3:25 - 3:35
Regen BioPharma Inc. (OTC Pink: RGBP)
Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant
3:40 – 3:50
Jaguar Health, Inc. (NASDAQ: JAGX)
Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director
Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.
Register for the Conference here.
Submit Questions for any of the presenting companies to: This email address is being protected from spambots. You need JavaScript enabled to view it.
Replays: Subscribe to our YouTube Channel
About EmergingGrowth.com
Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.
About the Emerging Growth Conference
The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.
All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on www.EmergingGrowth.com.
If you believe or know of a company that might fit our audience, contact us here.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.
Contact:
Emerging Growth
Phone: 1-305-330-1985
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$1.02 |
Daily Change: | -0.03 -2.86 |
Daily Volume: | 190,966 |
Market Cap: | US$60.410M |
March 31, 2025 March 26, 2025 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load